Publications 2022

Simon C, Stielow B, Nist A, Rohner I, Weber LM, Geller M, Fischer S, Stiewe T, Liefke R. The CpG Island-Binding Protein SAMD1 Contributes to an Unfavorable Gene Signature in HepG2 Hepatocellular Carcinoma Cells. Biology 2022, 11, 557. DOI: 10.3390/biology11040557

Schmitz ML, Dreute J, Pfisterer M, Günther S, Kracht M, Chillappagari S. SIAH ubiquitin E3 ligases as modulators of inflammatory gene expression. Heliyon 2022 Mar 1;8(3):e09029. DOI: 10.1016/j.heliyon.2022.e09029

Klimovich B, Meyer L, Merle N, Neumann M, König AM, Ananikidis N, Keber CU, Elmshäuser S, Timofeev O, Stiewe T. Partial p53 reactivation is sufficient to induce cancer regression. J Exp Clin Cancer Res 2022 Mar 2;41(1):80. DOI: 10.1186/s13046-022-02269-6

Klimovich B, Merle N, Neumann M, Elmshäuser S, Nist A, Mernberger M, Kazdal D, Stenzinger A, Timofeev O, Stiewe T. p53 partial loss-of-function mutations sensitize to chemotherapy. Oncogene 2022 Feb;41(7):1011-1023. doi: 10.1038/s41388-021-02141-5

Merle N, Elmshäuser S, Strassheimer F, Wanzel M, König AM, Funk J, Neumann M, Kochhan K, Helmprobst F, Pagenstecher A, Nist A, Mernberger M, Schneider A, Braun T, Borggrefe T, Savai R, Timofeev O, Stiewe T. Monitoring autochthonous lung tumors induced by somatic CRISPR gene editing in mice using a secreted luciferase. Mol Cancer. 2022 Oct 3;21(1):191. doi: 10.1186/s12943-022-01661-2.

Priester J, Dreute J, Kracht M, Schmitz ML. Post-Transcriptional Control of mRNA Metabolism and Protein Secretion: The Third Level of Regulation within the NF-κB System. Biomedicines 2022, 10, 2108. DOI: 10.3390/biomedicines10092108

Preußer C, Stelter K, Tertel T, Linder M, Helmprobst F, Szymanski W, Graumann J, Giebel B, Reinartz S, Müller R, Weber G, & Pogge von Strandmann E. Isolation of native EVs from primary biofluids—Free-flow electrophoresis as a novel approach to purify ascites-derived EVs. Journal of Extracellular Biology, 1, e71. doi: 10.1002/jex2.71